Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years

Timo Vesikari, Maija Baer, Paul Willems

    Research output: Contribution to journalArticleScientificpeer-review

    44 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)153-158
    JournalThe Pediatric Infectious Disease Journal
    Volume26
    Issue number2
    DOIs
    Publication statusPublished - 2007
    Publication typeA1 Journal article-refereed

    Cite this